Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ecellix is a materials science and medtech company based in Seattle, Washington, specializing in the development of high-capacity silicon-dominant anode materials for lithium-ion batteries. The company's proprietary e-Si® technology aims to replace traditional graphite anodes, offering up to three times the capacity and significantly improving energy density. While its technology has broad applications in consumer electronics and electric vehicles, Ecellix specifically targets the medical device market, providing longer-lasting and smaller power sources for wearables and implantable devices. The company was founded by renowned semiconductor pioneer Jerry S. Woodall and focuses on commercializing porous silicon-carbon composite materials that address the expansion issues typically associated with silicon anodes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecellix.